Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy
Xiuting Liu, John M. Baer, Meredith L. Stone, Brett L. Knolhoff, Graham D. Hogg, Madeleine C. Turner, Yu Lan Kao, Alyssa G. Weinstein, Faiz Ahmad, Jie Chen, Andrew D. Schmidt, Jeffrey A. Klomp, Heather Coho, Kayjana S. Coho, Silvia Coma, Jonathan A. Pachter, Kirsten L. Bryant, Liang I. Kang, Kian Huat Lim, Gregory L. BeattyDavid G. DeNardo
Dive into the research topics of 'Stromal reprogramming overcomes resistance to RAS-MAPK inhibition to improve pancreas cancer responses to cytotoxic and immune therapy'. Together they form a unique fingerprint.